Valion Bio, Inc. (VBIO) stock
Close on Nov 13, 2026Market cap $2.20MP/E –Yield –
Valion Bio statistics
63 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Share statisticsIndustry
- Shares Change (YoY)
- 308.9%
- 10.8%
- Shares Change (QoQ)
- 44.2%
- 0.50%
- Float
- 4M
- 49M
- Shares Held by Insiders
- 4.77%
- 11.7%
- Shares Held by Institutions
- 0.38%
- 56.4%
Short sellingIndustry
- Short Interest
- 230,766
- –
- Short Interest Change
- 99.8%
- -0.80%
- Short % of Float
- 5.84%
- 9.01%
- Short % of Shares Outstanding
- 5.56%
- 6.30%
- Days to Cover
- 1.00
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $67.50
- –
- 52-Week Low
- $0.47
- –
- 20-Day Moving Average
- $0.70
- –
- 50-Day Moving Average
- $1.66
- –
- 200-Day Moving Average
- $13.56
- –
- Average True Range (14)
- $0.18
- –
- Price Change (1 Week)
- 3.80%
- -1.15%
- Price Change (1 Month)
- -57.0%
- -4.87%
- Price Change (3 Months)
- -88.4%
- -21.0%
- Price Change (6 Months)
- -97.6%
- -20.6%
- Price Change (YTD)
- -98.5%
- -23.6%
- Price Change (1 Year)
- -99.1%
- -22.4%
- Price Change (3 Years)
- -99.9%
- -29.5%
- Price Change (5 Years)
- -100.0%
- -77.9%
- Average Volume (10 Days)
- 88,304
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.07
- 0.70
- Relative Strength Index (14)
- 23.2
- 43.4
- Volatility (1 Year)
- 134.6%
- 80.1%
- Beta (5 Years)
- 0.66
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -472.7%
- -49.9%
- Return on Assets (ROA)
- -101.4%
- -40.6%
- Return on Invested Capital (ROIC)
- -562.3%
- -32.9%
- Return on Capital Employed (ROCE)
- -56.1%
- -37.9%
Financial positionIndustry
- Current Ratio
- 1.11
- 3.30
- Quick Ratio
- 0.69
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$360.58K
- -$689.41K
- Employee Count
- 52
- 74
- WACC
- 8.39%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $2.11M
- $17.76M
- Net Cash Per Share
- $0.51
- $0.80
- Equity (Book Value)
- $4.25M
- $53.89M
- Book Value Per Share
- $1.02
- $1.50
- Tangible Book Value
- -$1.45M
- $27.13M
- Working Capital
- $336.00K
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$99.00K
- -$1.00M
- FCF Per Share
- -$3.53
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -853.2%
- -21.8%
- FCF Yield
- -667.7%
- -9.44%
Scores and fair valueIndustry
- Altman Z-Score
- -4.47
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | VBIO | S&P 500 | Difference | VBIO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -65.9% | -3.0% | −62.8 pts | ||
| 3 months | -87.6% | -2.8% | −84.8 pts | ||
| Year to date | -98.5% | +11.5% | −110.0 pts | ||
| 1 year | -99.0% | +13.5% | −112.4 pts | ||
| 3 years | -99.9% | +77.7% | −177.6 pts | -91.7% | +21.1% |
| 5 years | -100.0% | +72.6% | −172.6 pts | -92.6% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M VBIO shares were sold short on Oct 30, 2026, up 99.8% from the previous report, or 5.84% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 39.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 230,766 | +99.8% | 1,684,819 | 1.0 |
| Oct 15, 2026 | 115,490 | +31.3% | 1,404,868 | 1.0 |
| Sep 30, 2026 | 87,968 | +128.9% | 5,958,426 | 1.0 |
| Sep 15, 2026 | 38,427 | -88.7% | 136,492 | 1.0 |
| Aug 31, 2026 | 340,186 | -79.3% | 786,030 | 1.0 |
| Aug 14, 2026 | 1,646,299 | +96.5% | 33,615,368 | 1.0 |
| Jul 31, 2026 | 837,868 | +217.5% | 1,312,092 | 1.0 |
| Jul 15, 2026 | 263,890 | +70.0% | 201,032 | 1.3 |
| Jun 30, 2026 | 155,235 | -40.4% | 252,050 | 1.0 |
| Jun 15, 2026 | 260,360 | +73.8% | 693,061 | 1.0 |
| May 29, 2026 | 149,795 | -26.3% | 76,109 | 2.0 |
| May 15, 2026 | 203,277 | -17.3% | 336,770 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?